Emcure Pharmaceuticals Limited
Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
01 / The disclosure
What the company shared
Emcure Pharmaceuticals Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
A question for your research
Check the authority, amount, company response and appeal status. A notice and a final liability are different stages.
Numbers found in document text 1 matches
Automatic text matches, not verified financial metrics. A match may come from a table heading or reporting year. Expand it to inspect the surrounding text and original page.
Rs. 57,73,96,732Page 1
Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 (“Listing Regulations”), we hereby submit that with respect to the ongoing litigations disclosed by Emcure Pharmaceuticals Limited (“the Company”) , in the Integrated Governance Reports filed, latest being for the quarter ended June 30, 2026, the Company has received various orders from the Income -tax Department imposing an aggregate penalty of Rs. 57,73,96,732 for Financial Year 2014-15 to Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22), as detailed in Annexure A.
View source pageThe evidence
Read the source excerpts
01Subject: Disclosure under Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”) – Regulatory Order(s)
Page 1
02Pursuant to Regulation 30 of the SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015 (“Listing Regulations”), we hereby submit that with respect to the ongoing litigations disclosed by Emcure Pharmaceuticals Limited (“the Company”) , in the Integrated Governance Reports filed, latest being for the quarter ended June 30, 2026, the Company has received various orders from the Income -tax Department imposing an aggregate penalty of Rs. 57,73,96,732 for Financial Year 2014-15 to Financial Year 2020-21 (Assessment Year 2015-16 to Assessment Year 2021-22), as detailed in Annexure A.
Page 1
03As per the disclosure made in Integrated Governance Report filed for the quarter ended June 30, 2026.
Page 2
04Orders received for the Financial Year 2014 -15 until Financial Year 2020 -21 (Assessment Year 2015-16 to Assessment Year 2021-22) imposing an aggregate penalty of Rs. 57,73,96,732/-
Page 2
Source & verificationView the disclosure trail
- Summary method
- Exchange-provided text; no generated financial figures
- Exchange identifier
- 106806130
- First collected
- 3 Oct 2026, 17:17 IST
- PDF extraction
- extracted · 2 pages read
- Extraction note
- Source excerpts; financial tables have not been validated.
- Document SHA-256
- b207ef1693ec92ed711fbb129679657fb164e7e15a2e0b6ccb5272852975d542